Us Congress 2023-2024 Regular Session

Us Congress House Bill HR1521

Introduced
9/27/24  

Caption

Expressing support for the designation of September 30, 2024, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

Impact

By recognizing September 30 as Rare Cancer Day, the resolution aims to bolster community engagement and funding for research focused on these lesser-known forms of cancer. This recognition can lead to heightened awareness and education efforts, potentially resulting in improved early diagnosis and treatment options for patients. The resolution emphasizes the medical community's role in developing effective treatments and encourages partnerships with researchers and organizations supporting cancer advancements.

Summary

House Resolution 1521 aims to express support for the designation of September 30, 2024, as 'Rare Cancer Day'. This initiative seeks to raise awareness about the challenges faced by patients with rare cancers and to highlight the importance of early diagnosis and treatment. The resolution draws attention to the fact that a significant number of cancer patients are diagnosed with rare cancers, with early detection proving challenging due to less recognizable symptoms. The bill underscores the need for increased awareness both among patients and healthcare providers to improve survival rates.

Contention

While the bill is primarily supportive, there may be varying opinions on the allocation of resources for rare cancers compared to more common forms of cancer. Advocates for rare cancer treatment may argue for the necessity of more funding and research into less prevalent cancers, as existing options for these patients are often limited. There may be discussions about the urgency of early detection and the challenges faced by individuals and families impacted by rare cancers.

Companion Bills

US HR725

Same As Expressing support for the designation of September 30, 2023, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

Previously Filed As

US HR725

Expressing support for the designation of September 30, 2023, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

US HR1511

Expressing support for the designation of September 2024 as "National Prostate Cancer Awareness Month".

US HR1508

Supporting the designation of September 2024 as "National Ovarian Cancer Awareness Month".

US HR1595

Expressing support for the designation of November 2024 as "National Lung Cancer Awareness Month" and expressing support for early detection and treatment of lung cancer.

US HR746

Supporting the designation of September 2023 as "National Ovarian Cancer Awareness Month".

US HR394

Expressing support for the designation of July 16, 2025, as "Glioblastoma Awareness Day".

US SR912

A resolution designating November 2024 as "National Lung Cancer Awareness Month" and expressing support for early detection and treatment of lung cancer.

US HR1203

Expressing support for the designation of July 17, 2024, as "Glioblastoma Awareness Day".

US HR700

Expressing support for the designation of September 2023 as "National Prostate Cancer Awareness Month".

US HR1264

Expressing support for the designation of May 2024 as "National Brain Tumor Awareness Month".

Similar Bills

No similar bills found.